Photographer: Daniel Acker/Bloomberg

Mylan’s EpiPen School Sales Trigger N.Y. Antitrust Probe

Updated on
  • Drugmaker has been criticized over increase in EpiPen price
  • Probe will focus on Mylan’s contracts with New York schools

New York state’s top cop opened an antitrust investigation into Mylan NV, saying the embattled drugmaker may have ripped off local school systems that purchased life-saving EpiPen shots for students.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.